Phase 2 Trial of LDE225 and Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma
Phase of Trial: Phase II
Latest Information Update: 29 May 2017
At a glance
- Drugs Lenalidomide (Primary) ; Sonidegib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 23 May 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Aug 2017.
- 24 Jun 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Jan 2017 as reported by ClinicalTrials.gov record.
- 24 Jun 2015 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.